Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
Related Articles
- Update on H.R. 8875 “Improving Home Dialysis Act of 2026.” Posted 07-16-2026
- Stickman Industries Offers Many Products for Home Dialysis Patients Posted 07-16-2026
- Who Qualifies for Home Dialysis? Posted 07-16-2026
- NxStage’s ICan Tool Can Help HD Patients Learn to Self-cannulate Posted 07-16-2026

